|
|
|
Soya and Bone Health
D. Lee Alekel, PhD, RD
Professor-In-Charge, Human
Metabolic Unit
Iowa State University
Ames,IA 50011 USA
Email:
alekel@iastate.edu
Homepage:
http://www.fcs.iastate.edu/fshn/faculty/alekel.htm
Soya contains a
myriad of substances purported to have health benefits, one of which is
on the skeleton. This review focuses on isoflavones (estrogen-like
compounds) because most published studies have been conducted on the
naturally occurring isoflavones from soya foods.
Observations suggest that soyabeans contribute to bone
health, as indicated by the low rate of hip fracture in Asians
originating from the Pacific Rim, the lower urinary calcium losses with
soya versus animal protein diets, the effectiveness of the synthetic
ipriflavone to prevent and treat postmenopausal osteoporosis, and the in
vitro and in vivo estrogenic activity of soya isoflavones.
The end-points that have been used to assess bone changes
include bone mineral density (BMD) measurements using dual-energy X-ray
absorptiometry (DXA) and circulating or urinary biochemical bone
markers. This summary of peer-reviewed papers concentrates on
prospective human studies examining the effect of isoflavone-rich soya
protein on BMD.
Four prospective studies have been published thus far
measuring bone mass as an outcome in response to soya isoflavone intake.
Two of these studies were designed specifically to examine bone as the
primary outcome. Two studies used soya protein isolate, one used soya
foods, and one examined usual soya food intake among Asians as the
source of isoflavones.
Evidence of a bone-protective effect of isoflavone-containing
soya is both intriguing and encouraging, but nevertheless speculative at
this time. Still, these human studies suggest that isoflavones may
attenuate lumbar spine bone loss in women. If continued throughout
menopause, this attenuation of loss might decrease lifetime osteoporotic
risk. Since a bone-remodeling cycle ranges from 30-80 weeks, these
short-term preliminary studies cannot address whether such bone-sparing
effects would be sustained long-term. We cannot determine whether the
reported bone-sparing effect is due to treatment or is an artifact of
the bone-remodeling transient, but a longer-term study in Asian women
suggests true bone sparing. A study of longer duration is needed to
resolve whether soya isoflavones will affect the remodeling balance in
favor of bone formation.
Read more about
Effects of Soya on Bone
Health in Post Menopausal Hormone Replacement Therapy....
Click Here |
Top
Top
|
|